The Assignment
Elephas is an emerging biotech company focusing on developing innovative cancer diagnostic products and services that enables accurate prediction of clinical treatment outcome and accelerate drug development.
The company has been operating in stealth mode for the past 10 years and was gearing up for their big unveiling at AACR in March 2022. For the conference, Elephas wanted a sizzle video to generate buzz and pique the interest and serve as a starting point for conversations on potential partnerships and investments.
The differentiator for Elephas is how they work with live tumor fragments that keeps the integrity of the tumor. Steroids and organoids do not do this, as they are artificially treated to get to a truer representation of the tumor. Elephas is the only platform today that does this.
Link to video on the elephas.com
Screen shots from Video
